BNTX - Dhuwit awis perusahaan BioNTech Pharma

Logo korporat perusahaan biontech.de (BNTX)

Despite the decline in profits from COVID-19 drugs, BioNTech SE (BNTX) relies on massive capital reserves. Technological superiority in mRNA and investments in oncology drive development, and GURU.Markets data is reflected in this free cash flow chart, where the value 15.80 serves as the baseline indicator. The company's success is based on clinical trial results and global demand for innovative vaccines.

BNTX - Cadangan dhuwit perusahaan BioNTech Inc. ing rentang 04.07.2022 - 21.11.2026

Rincian metrik keuangan lan pasar BioNTech Group (BNTX)

- nilai saham lan prakiraan konsensus rega:
Pambiji fundamental:BNTX biontech.de
Produk merek BioNTech Inc.

For BioNTech SE (BNTX), a strategic liquidity reserve is critical for financing costly developments in the field of onco-immunology. This metric aggregates available cash and highly liquid deposits, reflecting the business's actual autonomy from credit markets. Analyzing the level of cash capital allows for tracking the dynamics of reinvesting windfall profits into new mRNA projects. A high cash balance confirms the issuer's financial stability as it transitions into new market niches.

Pesaing utama

Volume dana dhuwit perusahaan ARGX|Dana dhuwit perusahaan ABVX (ABIVAX)|ADMA Biologics, Inc. - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan Protagonist PTGX|IMVT - Dana dhuwit perusahaan|Aset likuid perusahaan Kiniksa Pharmaceuticals Ltd KNSA|grifols.com (GRFS) - Dana dhuwit perusahaan|ADPT (Adaptive Biotechnologies) - Dana dhuwit perusahaan|Dhuwit awis perusahaan CLDX|AUPH: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan BCRX|VERA (Vera Pharma) - Sisa dhuwit perusahaan|Dianthus Pharma - Dhuwit awis perusahaan|Sisa dhuwit perusahaan PHVS|AbCellera Biologics - Volume dana dhuwit perusahaan|Sisa dhuwit perusahaan TRML (Tourmaline Bio)|PGEN: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Pharming Group N.V. (PHAR)|Dana dhuwit perusahaan Nektar|upstreambio.com (UPB) - Aset likuid perusahaan|Dana dhuwit perusahaan Zenas Bio (ZBIO)|Aset likuid perusahaan Immunome Inc|Dana dhuwit perusahaan Gossamer Bio, Inc. GOSS|Volume dana dhuwit perusahaan KalVista Pharmaceuticals Inc KALV|SEPN - Dana dhuwit perusahaan|PVLA - Volume dana dhuwit perusahaan|SVRA: Volume dana dhuwit perusahaan|RIGL - Aset likuid perusahaan|ANAB (AnaptysBio Inc) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Astria Corp (ATXS)|Volume dana dhuwit perusahaan ENGN|Aset likuid perusahaan rapt.com|Volume dana dhuwit perusahaan JBIO (Aerovate Therapeutics Inc)|Aset likuid perusahaan Aclaris Therapeutics, Inc. (ACRS)|KYTX - Dana dhuwit perusahaan|Aset likuid perusahaan Tiziana Life Sciences TLSA|CABA: Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan VTYX|Dhuwit awis perusahaan THTX|Volume dana dhuwit perusahaan Avalo Therapeutics Inc.|Dana dhuwit perusahaan Eledon (ELDN)|Volume dana dhuwit perusahaan Agenus Inc (AGEN)|Volume dana dhuwit perusahaan CLYM (climbbio.com)|ZURA - Dhuwit awis perusahaan|atyrpharma.com - Volume dana dhuwit perusahaan|ADAG (adagene.com) - Dhuwit awis lan setara dhuwit awis perusahaan|IMA (Ikena Oncology) - Dhuwit awis perusahaan|Dhuwit awis perusahaan Shattuck Labs Inc|EQ (Equillium Inc) - Volume dana dhuwit perusahaan|CNTB: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan IMUX|ATRA (Atara Biotherapeutics, Inc.) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan IFRX (inflarx.de)|X4 Pharmaceuticals - Dana dhuwit perusahaan|Adicet Bio, Inc. - Volume dana dhuwit perusahaan|CELU (celularity.com) - Dhuwit awis lan setara dhuwit awis perusahaan|INMB: Volume dana dhuwit perusahaan|Barinthus Biotherapeutics PLC (BRNS) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Kezar Life Sciences|Dhuwit awis perusahaan SAB Biotherapeutics (SABS)|Dana dhuwit perusahaan Akari Therapeutics Plc (AKTX)|Dhuwit awis perusahaan Enlivex Therapeutics, Ltd. ENLV|Q32 Bio Inc. - Dhuwit awis perusahaan|GeoVax Labs (GOVX) - Cadangan dhuwit perusahaan|edesabiotech.com - Volume dana dhuwit perusahaan|Aset likuid perusahaan iBio Corp IBIO|CARM: Volume dana dhuwit perusahaan|xtlbio.com (XTLB) - Volume dana dhuwit perusahaan|BOLT (Bolt Biotherapeutics) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan HCW Biologics (HCWB)|Dhuwit awis perusahaan APVO (Aptevo Therapeutics)|AIM - Cadangan dhuwit perusahaan|Aditxt - Dhuwit awis perusahaan|Posisi dhuwit perusahaan gribio.com|XRTX: Dhuwit awis perusahaan|Sisa dhuwit perusahaan HIND (Vyome Holdings)|REVB (Revelation Bio) - Dhuwit awis perusahaan|Indaptus Corp (INDP) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan scinai.com|Dhuwit awis perusahaan CalciMedica, Inc. (CALI)|Dana dhuwit perusahaan Affimed NV (AFMD)|Dana dhuwit perusahaan ALLK (Allakos Inc)|Dana dhuwit perusahaan HOOKIPA Pharma, Inc. HOOK|Aset likuid perusahaan IGM Bio (IGMS)|iTeos Pharma - Volume dana dhuwit perusahaan|Aset likuid perusahaan oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan THRD